Top Markets
Coin of the day
Elevation Oncology, Inc. Elevation Oncology, Inc.

Elevation Oncology, Inc.

ELEV
Rang in aandelen #29359
Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company... Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company operating in the United States, committed to developing targeted cancer therapies for patients with specific genetic profiles. Its leading drug candidate is seribantumab, an anti-HER3 monoclonal antibody currently being evaluated in the Phase II CRESTONE trial. This study focuses on treating advanced solid tumors that harbor a neuregulin-1 fusion. The company was established in 2019 and is headquartered in New York, New York.
Aandeelprijs
$0.365
Laatst gesynchroniseerd: 2025-08-01
Marktkapitalisatie
$21.54M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel Elevation Oncology, Inc. (ELEV)

Categorie

Koersgeschiedenis voor Elevation Oncology, Inc. (ELEV)
Hoogste slotkoers: $0.37 op 2025-08-01

Laagste slotkoers: $12.36 op 2021-06-01
Koersgeschiedenis van Elevation Oncology, Inc. van 2021 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2025 -40.93%
2024 21.56%
2023 -47.33%
2022 -81.61%
2021 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$543.58 39.11%
US
$1.02K 55.96%
NL
$149.47 435.54%
US
$117.42 -19.34%
AU
$755.62 8.92%
CH